Abstract
Uptake and incorporation of long-chain fatty acids were studied in a human colorectal cancer cell line (HT29/219) grown in culture medium supplemented with either fetal calf serum (FSC) or horse serum (HS). The cells were grown for 120 h with no change of medium; the two major cellular lipid classes, the phospholipids and the triacylglycerols, were analyzed at regular time-points. We observed significant changes in the concentration of most fatty acids throughout culture, and differences in their composition when different sera were used to supplement the medium. Minimal levels of free fatty acids were found in the cells, indicating a very small “free fatty acid pool”. A major difference between the cells grown in media supplemented with different sera was the changes observed in concentrations of cellular polyunsaturated fatty acids during growth. In cells grown with FCS (in which 20∶4n−6 is present), the levels of this acid in the phsopholipid and triacylglycerol fractions declined rapidly during cell growth, suggesting further metabolism. In cells grown in medium supplemented with HS, 18∶2n−6 was the major polyunsaturated acid present. There was clear evidence that this acid accumulated in the cellular triacylglycerol and phospholipid fractions. Furthermore, its concentration did not decline during growth in culture, suggesting minimal conversion to other polyunsaturated n−6 acids. Our results suggest that fatty acids from additional sources in the medium, for example triacylglycerols and phospholipids associated with the lipoproteins, are taken up by the cells. There is also indication of cellular fatty acid synthesis, particularly of monounsaturated and saturated acids during the culture period. HT29/219 cells were shown to take up and incorporate radioactivity when trace amounts of [1-14C]-labeled arachidonic, linoleic or oleic acids were added to the culture medium. Most (80%) of the label was detected in cellular phospholipids and triacylglycerols, although the specific activities of these various fatty acids were different in the two lipid fractions.
Similar content being viewed by others
Abbreviations
- BHI:
-
brain heart infusion
- BHT:
-
butylated hydroxytoluene
- DFC10:
-
DMEM enriched with 10% fetal calf serum (vol/vol)
- DH10:
-
DMEM enriched with 10% horse serum (vol/vol)
- DMEM:
-
Dulbecco's modification of Eagle's essential medium
- EDTA:
-
ethylenediaminetetraacetic acid
- FAME:
-
fatty acid methyl esters
- FCS:
-
fetal calf serum
- GC/MS:
-
gas chromatography/mass spectrometry
- HPLC:
-
high-performance liquid chromatography
- HS:
-
horse serum
- PBS:
-
phosphate buffered saline
- SAB:
-
Sabouraud liquid medium
- TLC:
-
thin-layer chromatography
References
Spector, A.A., Mathur, S.N., Kaduce, T.L., and Hyman, B.T. (1981)Prog. Lipid Res. 19, 155–186.
Bailey, J.M., Howard, B.V., and Tillman, S.F. (1973)J. Biol. Chem. 248, 1240–1247.
Howard, B.V., and Kritchevsky, D. (1969)Biochim. Biophys. Acta 187, 293–301.
Mackenzie, C.G., Mackenzie, J.B., Reiss, O.K., and Wisneski, J.A. (1970)J. Lipid Res. 11, 571–582.
Yorek, M.A., Strom, D.K., and Spector, A.A. (1984)J. Neurochem. 42, 254–261.
Spector, A.A., and Burns, C.P. (1987)Cancer Res. 47, 4529–4537.
Pesce, M.A., and Strande, C.S. (1973)Clin. Chem. 19, 1265–1267.
Lowry, O.H., Rosebrough, N.J., Farr, A.L., and Randall, R.J. (1951)J. Biol. Chem. 193, 265–275.
Zondag, H.A., and van Boetzelaer, G.L. (1960)Clin. Chim. Acta 5, 155–156.
Folch, J., Lees, M., and Sloane Stanley, G.H. (1957)J. Biol. Chem. 226, 497–509.
Christie, W.W. (1982)Lipid Analysis, 2nd edn., p. 38, Pergamon Press, Oxford.
Christie, W.W. (1982)J. Lipid Res. 23, 1072–1075.
Christie, W.W. (1989)Gas Chromatography and Lipids. A Practical Guide, pp. 70–71, The Oily Press, Ayr.
Pazouki, S., Baty, J.D., Wallace, H.M., and Coleman, C.S. (1990)Analyst 115, 517–519.
Sampson, D., and Hensley, W.J. (1975)Clin. Chim. Acta 61, 1–8.
Stoll, L.L., and Spector, A.A. (1984)In Vitro 20, 732–738.
Delplanque, B., and Jacotot, B. (1987)Lipids 22, 241–249.
Kidwell, W.R., Monaco, M.E., Wicha, M.S., and Smith, G.S. (1978)Cancer Res. 38, 4091–4100.
Isseroff, R.R., Martinez, D.T., and Ziboh, V.A. (1985)J. Invest. Dermatol. 85, 131–134.
Spector, A.A. (1972) inGrowth, Nutrition, and Metabolism of Cells in Culture (Rothblat, G.H., and Cristafalo, V.J., eds.) Vol. 1, pp. 257–296, Academic Press Inc., New York.
Simon, I., Burns, C.P., and Spector, A.A. (1982)Cancer Res. 42, 2715–2721.
Spector, A.A., and Yorek, M.A. (1985)J. Lipid Res. 26, 1015–1035.
Faulkner, J., Ling, N.R., and Shakespere, M. (1987)Int. Biotechnol. Lab., 8–16.
Madison, K.C., Wertz, P.W., Strauss, J.S., and Downing, D.T. (1986)J. Invest. Dermatol. 87, 253–259.
Clouet, P., Niot, I., and Bezard, J. (1989)Biochem. J. 263, 867–873.
Howard, B.V., and Howard, W.J. (1975)Progr. Biochem. Pharmacol. 10, 135–166.
Maeda, M., Doi, O., and Akamatsu, Y. (1978)Biochim. Biophys. Acta 530, 153–164.
Doi, O., Doi, F., Schroeder, F., Alberts, A.W., and Vagelos, P.R. (1978)Biochim. Biophys. Acta 509, 239–250.
Booyens, J., Engelbrecht, P., le Roux, S., Louwrens, C.C., Van der Merve, C.F., and Katzeff, I.E. (1984)Prostag. Leukot. med. 15, 15–33.
Author information
Authors and Affiliations
About this article
Cite this article
Pazouki, S., Baty, J.D., Wallace, H.M. et al. Utilization of extracellular lipids by HT29/219 cancer cells in culture. Lipids 27, 827–834 (1992). https://doi.org/10.1007/BF02535858
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02535858